Drug
Niclosamide clinical trials
Also written ANA001.
- studies test it
- 25
- open now
- 2
- in phase 3
- 3
- first study started
- 2004
Keep track of what changes. Save the Niclosamide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
25 studies that test it; most in 2020 (7)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 13
- Phase 3
- 3
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 16
Entero Therapeutics (4) · NeuroBo Pharmaceuticals Inc. (2) · Charité Research Organisation GmbH (2) · Mamta Parikh (1) · University of California, Davis (1) · Chulalongkorn University (1) · Tanta University (1) · Tufts Medical Center (1)
Often tested with
Tested in the same studies.
Enzalutamide (3) · Abiraterone Acetate (1) · Abiraterone (1) · Prednisone (1) · Fluvoxamine (1) · Bromhexine (1) · Cyproheptadine (1) · Camostat (1)
Studies
Open first, then newest update. How each study uses Niclosamide is read from its arms, and is right about nine times in ten.
Testing it · 25
- Niclosamide in Pediatric Patients With Relapsed and Refractory AMLRecruitingPhase 1Stanford UniversityNCT05188170Written as Niclosamide
- Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate CancerNot yet recruitingPhase 1Hyundai Bioscience Co., Ltd.NCT07683013Written as CP-PCA07
- Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate CancerCompletedPhase 1University of California, DavisNCT03123978Written as Niclosamide
- Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) PatientsCompletedPhase 2/3NeuroBo Pharmaceuticals Inc.NCT04603924Written as Niclosamide
- A Single and Multiple Ascending Dose Study of Niclosamide in Healthy VolunteersCompletedPhase 1NeuroBo Pharmaceuticals Inc.NCT04705415Written as Niclosamide
- Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerActive, not recruitingPhase 2Mamta ParikhNCT02807805Written as Niclosamide
- Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal InfectionTerminatedPhase 2Entero TherapeuticsNCT04858425Written as Niclosamide
- A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative ProctosigmoiditisTerminatedPhase 1/2Entero TherapeuticsNCT03521232Written as Niclosamide
- Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in CommunityCompletedPhase 4Chulalongkorn UniversityNCT05087381Written as Niclosamide, Bromhexine
- Niclosamide Role in Diabetic NephropathyCompletedPhase 3Tanta UniversityNCT04317430Written as Niclosamide
- Niclosamide for Mild to Moderate COVID-19CompletedPhase 2Tufts Medical CenterNCT04399356Written as Niclosamide
- Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19TerminatedPhase 2UNION therapeuticsNCT04932915Written as Niclosamide
- Niclosamide In Moderate COVID-19WithdrawnPhase 2Entero TherapeuticsNCT04436458Written as Niclosamide Oral Tablet
- Niclosamide in COVID-19WithdrawnPhase 2Entero TherapeuticsNCT04542434Written as Niclosamide Oral Tablet
- Safety and Preliminary Efficacy of the Combination of Niclosamide and CamostatTerminatedPhase 2Charité Research Organisation GmbHNCT04750759Written as Niclosamide + Camostat
- Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With CamostatCompletedPhase 1Charité Research Organisation GmbHNCT04644705Written as Niclosamide
- Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 ManagementStatus unknownPhase 2University of BaghdadNCT04753619Written as Niclosamide Oral Tablet
- A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19Status unknownPhase 3Imuneks Farma ilac San. Tic. A.S.NCT04558021Written as Niclosamide suspension
- Niclosamide for Familial Adenomatous PolyposisStatus unknownPhase 2Yonsei UniversityNCT04296851Written as Niclosamide
- A Study of Niclosamide in Patients With Resectable Colon CancerTerminatedPhase 1Michael Morse, MDNCT02687009Written as Niclosamide
See all 25 studies that test Niclosamide →
As the comparator · 1 — what is tested is compared with Niclosamide
Codes
What other systems call Niclosamide · ClinicalTrials.gg INT007886
- MeSH (NLM) D009534NiclosamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 8KK8CQ2K8GNICLOSAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 7402Confirmed FDA, Wikidata
- Wikidata Q418523niclosamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66240NiclosamideOne source FDA
- DrugBank DB06803One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009534 | Niclosamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 8KK8CQ2K8G | NICLOSAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7402 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418523 | niclosamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66240 | Niclosamide | One source FDA |
| DrugBank | DB06803 | — | One source Wikidata |
Also registered as niclosamide-olamine (UNII QT8YUD1Z0W).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.